0.00
price down icon100.00%   -5.00
 
loading
Schlusskurs vom Vortag:
$5.00
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$266.14M
Einnahmen:
$44.12M
Nettoeinkommen (Verlust:
$-156.25M
KGV:
0.00
EPS:
-3.07
Netto-Cashflow:
$-154.61M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$5.30

2 Seventy Bio Inc Stock (TSVT) Company Profile

Name
Firmenname
2 Seventy Bio Inc
Name
Telefon
339-499-9300
Name
Adresse
60 BINNEY STREET, CAMBRIDGE
Name
Mitarbeiter
65
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-25
Name
Neueste SEC-Einreichungen
Name
TSVT's Discussions on Twitter

Vergleichen Sie TSVT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TSVT
2 Seventy Bio Inc
0.00 266.14M 44.12M -156.25M -154.61M -3.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
369.12 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
562.01 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
431.81 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
664.28 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
289.89 35.49B 3.81B -644.79M -669.77M -6.24

2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-06-06 Herabstufung Goldman Neutral → Sell
2024-01-31 Hochstufung Leerink Partners Market Perform → Outperform
2024-01-31 Herabstufung TD Cowen Outperform → Market Perform
2023-10-30 Herabstufung Leerink Partners Outperform → Market Perform
2023-10-12 Eingeleitet Citigroup Buy
2023-09-13 Herabstufung Goldman Buy → Neutral
2023-09-12 Herabstufung Guggenheim Buy → Neutral
2023-07-28 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-10-31 Eingeleitet Guggenheim Buy
2022-05-02 Eingeleitet Goldman Buy
2022-02-10 Eingeleitet SVB Leerink Outperform
2022-01-06 Eingeleitet Cowen Outperform
2021-11-09 Eingeleitet Canaccord Genuity Buy
2021-11-08 Eingeleitet Morgan Stanley Overweight
2021-11-08 Eingeleitet Wedbush Outperform
Alle ansehen

2 Seventy Bio Inc Aktie (TSVT) Neueste Nachrichten

pulisher
07:31 AM

Is now a turning point for 2seventy bio Inc.Free Real Trader Watchlist of Hot Stocks - Newser

07:31 AM
pulisher
06:21 AM

Real time pattern detection on 2seventy bio Inc. stockLow Risk Stock Selection Strategy Guide - Newser

06:21 AM
pulisher
Aug 07, 2025

Analyzing net buyer seller activity in 2seventy bio Inc.Scalable Strategy with Chart Confirmation - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

How 2seventy bio Inc. stock performs during market volatilityControlled Entry Strategy With Safety Analytics - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Long term hold vs stop loss in 2seventy bio Inc.Free Safe Entry Stock Watch Suggestions - Newser

Aug 07, 2025
pulisher
Aug 06, 2025

Momentum divergence signals in 2seventy bio Inc. chartFree Weekly Hot Picks With Buy Confidence - Newser

Aug 06, 2025
pulisher
Aug 04, 2025

Live Scanner Shows Breakout on 2seventy bio Inc.Watchlist for Smart Swing Trading Updated - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Traders Consider Averaging Down in 2seventy bio Inc.Exit Ready Momentum Stock Watchlist Expanded - beatles.ru

Aug 04, 2025
pulisher
Aug 03, 2025

What drives 2seventy bio Inc. stock priceAchieve rapid portfolio growth with expert guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does 2seventy bio Inc. compare to its industry peersFree Stock Market Forecast Reports - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

2seventy bio Inc. Stock Analysis and ForecastConsistent double returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about 2seventy bio Inc.Achieve rapid financial growth with expert help - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for 2seventy bio Inc. in the next 12 monthsDiscover breakthrough trading strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate 2seventy bio Inc. as a “Buy”Explosive portfolio gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell 2seventy bio Inc. stock in 2025Superior trading gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does 2seventy bio Inc. generate profit in a changing economyCapitalize on market momentum for maximum gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of 2seventy bio Inc. stockCapitalize on fast-growing investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes 2seventy bio Inc. stock price move sharplyConsistently superior profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is 2seventy bio Inc. stock overvalued or undervaluedHigh-profit stock alerts - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Why is 2seventy bio Inc. stock attracting strong analyst attentionUnbelievable profit margins - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the latest earnings results for 2seventy bio Inc.Get expert insights on market-moving stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is 2seventy bio Inc. stock expected to show significant growthSpectacular growth rates - Jammu Links News

Aug 02, 2025
pulisher
Jul 29, 2025

Is 2seventy bio Inc. Stock a Good Fit for Conservative InvestorsBuy Alerts With Low Risk Confirmation Noted - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Is 2seventy bio Inc. forming a reversal patternTechnical Stock Breakout Predictions Signal Entry Points - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Momentum Screeners Rank 2seventy bio Inc. in Top 5 TodayAlpha Driven Watchlist With Alerts Published - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Heatmap Data Shows High Activity in 2seventy bio Inc. SectorReal Time Alerts Based on AI Prediction Triggered - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Sector Leaders Rotate Capital Into 2seventy bio Inc.Breakout Confirmation With Entry Tracker Enabled - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

2seventy bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayAI Powered Stock Call - metal.it

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive 2seventy bio Inc. stock higher in 2025Track emerging stocks with high growth potential - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is 2seventy bio Inc. company’s balance sheetAchieve consistent double-digit growth - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 15:37:28 - Jammu Links News

Jul 27, 2025
pulisher
Jul 25, 2025

Can 2seventy bio Inc. stock recover from recent declineExplosive earning power - Jammu Links News

Jul 25, 2025
pulisher
Jul 23, 2025

Why 2seventy bio Inc. stock attracts strong analyst attentionTop Performing Stocks - beatles.ru

Jul 23, 2025
pulisher
Jul 22, 2025

Is 2seventy bio Inc. a good long term investmentDynamic investment growth - Jammu Links News

Jul 22, 2025
pulisher
Jul 14, 2025

Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis - Ophthalmology Times

Jul 14, 2025
pulisher
Jun 13, 2025

FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades - Managed Healthcare Executive

Jun 13, 2025
pulisher
Jun 12, 2025

Cigna Launches AI Tools to Simplify Health Insurance, Improve Customer Experience - Managed Healthcare Executive

Jun 12, 2025
pulisher
Jun 12, 2025

FDA Approves Ibtrozi For Adults With ROS1+ NSCLC - Managed Healthcare Executive

Jun 12, 2025
pulisher
Jun 12, 2025

Alachua bio-manufacturing plant to lay off employees ahead of shutdown - WCJB | TV20

Jun 12, 2025
pulisher
Jun 12, 2025

'Life is too short to work on things that are mediocre': Why this biotech CEO's 2nd drug approval is a big deal - The Business Journals

Jun 12, 2025
pulisher
Jun 11, 2025

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC - Pharmacy Times

Jun 11, 2025
pulisher
Jun 09, 2025

Bonnie Hui-Callahan, Pharm.D., Video Interview | 2025 MHE Emerging Leaders in Healthcare - Managed Healthcare Executive

Jun 09, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Reduces Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Makes New Investment in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jun 05, 2025
pulisher
May 26, 2025

Deutsche Bank AG Has $1.10 Million Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

May 26, 2025
pulisher
May 18, 2025

MHE Week in Review –Medicaid Bill Mayhem, UnitedHealth’s Stock Plummets and More - Managed Healthcare Executive

May 18, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Makes New $52,000 Investment in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

May 15, 2025
pulisher
May 15, 2025

2Seventy Bio Reports Strong Q1 2025 Earnings - TipRanks

May 15, 2025
pulisher
May 14, 2025

Investor relations - Bristol Myers Squibb

May 14, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Has $96,000 Stake in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

May 13, 2025
pulisher
May 13, 2025

2seventy bio completes merger with Bristol-Myers Squibb - Investing.com

May 13, 2025

Finanzdaten der 2 Seventy Bio Inc-Aktie (TSVT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$78.25
price up icon 0.06%
$37.38
price up icon 0.98%
$107.73
price down icon 1.57%
$28.88
price up icon 2.97%
$111.95
price up icon 0.54%
biotechnology ONC
$289.85
price down icon 3.16%
Kapitalisierung:     |  Volumen (24h):